Solutions
About Us
Insights
Careers

Further Practical Guidance on Adjusting Time-To-Event Outcomes for Treatment Switching. Watkins C, Kleine E, Miranda M, Bourmaud E, Doehring O. Pharmaceutical Statistics. 2025

A Comparison of Two Methods for Adaptive Multi-Arm Two-Stage Design. Mehta C, Kappler M. Statistics in Medicine. 2025

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Fayette J, Licitra L, Harrington K, Haddad R, Siu LL, Liu YC, Tahara M, Machiels JP, Rischin D, Seiwert TY, Ferris RL, Keilholz U, Psyrri A, Keam B, Bossi P, Metcalf R, Hsieh CY, Clement PMJ, Isaev P, Mudunov A, Dinis J, Hoeben A, Kasper S, Klinghammer K, Hwang M, Blando J, Serrano O, Ruscica D, Cohen RB; INTERLINK-1 investigators. Clinical Cancer Research. 2025

Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study. Wiendl H, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, Hodgkinson S, Prat A, Leocani L, Schmierer K, Sellebjerg F, Vermersch P, Jin H, Chudecka A, Kloetgen A, Lin D, Gardner L, De Stefano N. Neurology and Therapy. 2025

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer. Janjigian YY, Al-Batran SE, Wainberg ZA, Muro K, Molena D, Van Cutsem E, Hyung WJ, Wyrwicz L, Oh DY, Omori T, Moehler M, Garrido M, Oliveira SCS, Liberman M, Oliden VC, Smyth EC, Stein A, Bilici M, Alvarenga ML, Kozlov V, Rivera F, Kawazoe A, Serrano O, Heilbron E, Negro A, Kurland JF, Tabernero J; MATTERHORN Investigators. The New England Journal of Medicine. 2025

Webinar – Boosting Efficiency with CRF and CDISC Standards

Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps, Joshua S. Jacobs, Joseph K. Han, Jason K. Lee, Tanya M. Laidlaw, Nicole L. Martin, Scott Caveney, Christopher S. Ambrose, Neil Martin, Joseph D. Spahn & Flavia C. L. Hoyte, Advances in Therapy 2025

White Paper – Clinical Trial SAS Programming Needs a Makeover: Agile Leads the Way

Webinar – R-Integration Series Part 5: A Closer Look at Assurance: Sampling Patient Outcomes from Prior Distributions to Account for Uncertainty in Response Scenarios

White Paper – ICH E20 Ushers in a New Era for Adaptive Designs in Clinical Development